4.3 Review

Pacemaker implantation after transcatheter aortic valve: why is this still happening?

期刊

JOURNAL OF THORACIC DISEASE
卷 10, 期 -, 页码 S3614-S3619

出版社

AME PUBL CO
DOI: 10.21037/jtd.2018.06.103

关键词

Aortic stenosis; atrio-ventricular block; conduction disorder; permanent pacemaker (PPM)

资金

  1. Boston Scientific
  2. Abbott
  3. Biotronik
  4. Biosense Webster
  5. Metronic

向作者/读者索取更多资源

During the past years, the industry and most transcatheter aortic valve operators have focused on reduction of paravalvular leaks rather than on the reduction of permanent pacemakers (PPM). However, since indication for transcatheter aortic valve implantation (TAVI) is moving toward a healthier and younger patient population, new PPMs may become more of an issue. Certain factors such as pre-existing conduction disorders or anatomical features cannot be changed. However, the amount of mechanical trauma to the conduction system and periprocedural medical management offers the potential for optimization. By optimizing our procedure, we may finally be able to achieve low, surgical-like, PPM rates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据